Find out more about gSynthTM and how it can enable new synthetic biology applications

See the infographic

Synthetic biology is changing the world

  • 4 March 2019

Camena Bioscience CEO, Steve Harvey, discusses synthetic biology tools and the importance of being able to produce synthetic DNA and RNA molecules.

Read More

Accelerating time to market of new biologic medicines with improved small molecule analysis

  • 25 April 2018

Camena Bioscience’s innovative sensor technology is being developed into an easy to use research instrument that aims to improve the efficiency and cost of manufacturing medicines. Innovate UK, the UK’s innovation agency, is co-funding a £1.6m project to develop our revolutionary small molecule detection technology. Camena Bioscience will take the lead on this project collaborating with GSK, The Centre for Process Innovation (CPI) and TTP.

Read More